Skip to main content
Fig. 10 | Journal of Biomedical Science

Fig. 10

From: Characterization of a murine xenograft model for contrast agent development in breast lesion malignancy assessment

Fig. 10

DCE-MDCT of xenografts. The acquisition at time points post iobitridol injection is indicated below each image with the positions of the MDA-MB 231 xenografts indicated by red arrows and the benign xenografts indicated by white arrow heads. a The rim enhancement of malignant xenografts (MDA-MB 231) was demonstrated after iobitridol administration. b The green lines marked areas in (a) are magnified to demonstrate the angular/ill-defined margin (orange arrows) of malignant xenografts (MDA-MB 231)

Back to article page

Journal of Biomedical Science

ISSN: 1423-0127